SG Americas Securities LLC Sells 144,236 Shares of Corteva, Inc. $CTVA

SG Americas Securities LLC trimmed its position in shares of Corteva, Inc. (NYSE:CTVA) by 28.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 371,650 shares of the company’s stock after selling 144,236 shares during the quarter. SG Americas Securities LLC’s holdings in Corteva were worth $31,111,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of CTVA. JPL Wealth Management LLC bought a new stake in Corteva during the 3rd quarter valued at $25,000. Garton & Associates Financial Advisors LLC bought a new position in shares of Corteva in the fourth quarter valued at $27,000. Bank of Jackson Hole Trust bought a new position in shares of Corteva in the fourth quarter valued at $28,000. Cornerstone Financial Management LLC acquired a new position in shares of Corteva during the fourth quarter valued at about $29,000. Finally, Basepoint Wealth LLC bought a new stake in shares of Corteva during the fourth quarter worth about $30,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Up 0.6%

CTVA opened at $79.36 on Wednesday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The firm has a market capitalization of $53.08 billion, a P/E ratio of 46.68, a PEG ratio of 2.41 and a beta of 0.57. The company’s 50-day moving average is $79.45 and its 200 day moving average is $75.95. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 42.35%.

Analyst Upgrades and Downgrades

CTVA has been the topic of a number of analyst reports. Argus upped their target price on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, March 31st. Oppenheimer boosted their price objective on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. BNP Paribas Exane boosted their price objective on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Jefferies Financial Group increased their price objective on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Finally, Royal Bank Of Canada raised their target price on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $88.81.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.